Trial Profile
Efficacy and tolerability of veltuzumab + chemotherapy with rituximab + chemotherapy in patients with newly diagnosed follicular lymphoma
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 05 Feb 2010
Price :
$35
*
At a glance
- Drugs Antineoplastics (Primary) ; Rituximab (Primary) ; Veltuzumab (Primary)
- Indications Follicular lymphoma
- Focus Registrational; Therapeutic Use
- 05 Feb 2010 New trial record.